In a different study, Ulrich and colleagues investigated the role of bradykinin, a pro-metastatic factor, as a promoter of neuroblastoma metastasis in bone marrow, exploring different molecular pathways involved in cancer invasiveness, among which the P2X7 receptor is included [38]. The gene discussed is P2RX7; the disease is neuroblastoma.